logo

6.02

6.02 (-0.13%)

As of Mar 06, 2024

Inozyme Pharma, Inc. [INZY]

Source: 

Company Overview

Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue and skeleton. Through our in-depth understanding of a key biological pathway, we are pursuing the development of therapeutics to address the underlying causes of these debilitating diseases.

CountryUnited States
Headquartersbostonmassachusetts
Phone Number857-330-4340
Industry
manufacturing
CEOAxel Bolte
Websitewww.inozyme.com